FDA warns Aspen Pharmacare over eye drop production standards

The US FDA has warned Aspen Pharmacare, Africa's largest drugmaker, citing breaches in manufacturing standards for eye drops produced at its Gqeberha facility.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged Aspen Pharmacare, Drug Safety, Exports, Eye Drops, FDA, healthcare, Pharmaceutical Manufacturing, Quality Control, Regulatory Compliance., South Africa